IndraLab

Statements

COPS5 inhibits PARP1. 1 / 1

| 1

reach

"Inhibiting CSN5 strongly attenuates prostate cancer progression and could enhance PARP inhibition efficacy in the treatment of prostate cancer."

34802033

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

COPS5 inhibits PARP1. 1 / 1

INDRA sources:

Databases

Reading